Corvus Pharmaceuticals (CRVS) Institutional Ownership

$1.45
-0.03 (-2.03%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

Current
Institutional Ownership
Percentage
46.64%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$1.11M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$5.13M
Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/1/2024Towerview LLC436,873$769K0.5%+27.6%0.891%
11/13/2023Connor Clark & Lunn Investment Management Ltd.70,883$103K0.0%-16.0%0.145%
11/4/2023Towerview LLC342,478$500K0.3%+67.1%0.699%
9/8/2023Tucker Asset Management LLC12,871$29K0.0%N/A0.026%
8/22/2023CHI Advisors LLC200,000$458K0.1%-91.5%0.408%
8/11/2023MYDA Advisors LLC100,000$229K0.1%N/A0.204%
8/7/2023Acadian Asset Management LLC58,069$132K0.0%-55.9%0.125%
8/3/2023Towerview LLC205,000$469K0.3%N/A0.440%
7/27/2023Virtu Financial LLC25,542$58K0.0%+32.0%0.055%
5/11/2023CHI Advisors LLC2,339,402$2.13M0.6%-1.9%5.024%
2/14/2023Discovery Capital Management LLC CT548,727$466K0.1%N/A1.179%
11/17/2022Telemetry Investments L.L.C.522,009$427K0.5%+13.5%1.121%
10/18/2022Bailard Inc.39,998$33K0.0%N/A0.086%
4/20/2022 Jackson Square Capital LLC63,773$105K0.0%N/A0.137%
4/13/2022Hikari Power Ltd49,959$82K0.0%+150.3%0.107%
2/15/2022Coastal Bridge Advisors LLC24,000$58K0.0%N/A0.052%
2/14/2022Point72 Asset Management L.P.795,000$1.92M0.0%+38.3%1.708%
2/10/2022Acadian Asset Management LLC81,166$194K0.0%+96.9%0.174%
11/22/2021EcoR1 Capital LLC2,081,077$10.07M0.4%-41.9%4.471%
11/16/2021Squarepoint Ops LLC19,954$97K0.0%N/A0.043%
11/16/2021Tang Capital Management LLC3,749,379$18.15M3.8%N/A8.055%
11/16/2021Two Sigma Investments LP140,455$680K0.0%-54.6%0.302%
11/16/2021Two Sigma Securities LLC22,789$110K0.0%N/A0.049%
11/16/2021Telemetry Investments L.L.C.196,168$949K1.3%-25.7%0.421%
11/16/2021VR Adviser LLC3,427,461$16.59M2.1%N/A7.363%
11/16/2021BVF Inc. IL1,370,947$6.64M0.3%-62.7%2.945%
11/16/2021CHI Advisors LLC165,927$803K0.2%-76.9%0.356%
11/15/2021Point72 Asset Management L.P.575,000$2.78M0.0%N/A1.235%
11/15/2021Pura Vida Investments LLC734,268$3.55M0.1%N/A1.577%
11/15/2021Zacks Investment Management10,000$48K0.0%N/A0.021%
11/12/2021Affinity Asset Advisors LLC50,000$242K0.1%N/A0.107%
11/12/2021Renaissance Technologies LLC614,370$2.97M0.0%-6.6%1.320%
11/12/2021DC Investments Management LLC50,709$245K0.5%N/A0.109%
11/12/2021MYDA Advisors LLC60,000$290K0.1%N/A0.129%
11/12/2021Geode Capital Management LLC210,243$1.02M0.0%+10.9%0.452%
11/12/2021Artal Group S.A.500,000$2.42M0.1%N/A1.074%
11/9/2021BlackRock Inc.100,451$486K0.0%-23.3%0.216%
11/5/2021Lindbrook Capital LLC14,000$68K0.0%N/A0.033%
8/17/2021BVF Inc. IL3,678,626$9.82M0.4%+13.9%8.672%
8/16/2021Telemetry Investments L.L.C.263,975$705K1.0%+6.0%0.622%
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
8/16/2021State Street Corp29,600$79K0.0%N/A0.070%
8/13/2021Renaissance Technologies LLC658,070$1.76M0.0%-0.8%1.551%
8/13/2021Northern Trust Corp59,262$158K0.0%+56.5%0.140%
8/13/2021Laurion Capital Management LP59,150$158K0.0%-79.0%0.139%
8/13/2021Algert Global LLC19,737$53K0.0%-53.9%0.047%
8/13/2021Natixis27,900$74K0.0%+69.1%0.066%
8/13/2021Geode Capital Management LLC189,541$506K0.0%+27.4%0.447%
8/13/2021Vanguard Group Inc.1,109,218$2.96M0.0%+10.9%2.615%
8/12/2021Dimensional Fund Advisors LP395,829$1.06M0.0%-5.0%0.933%
8/11/2021CHI Advisors LLC719,132$1.92M0.4%+5.9%1.695%
5/18/2021BVF Inc. IL3,229,426$9.95M0.4%+66.1%8.430%
5/18/2021Millennium Management LLC99,096$305K0.0%-18.5%0.259%
5/18/2021Orbimed Advisors LLC8,053,298$24.80M0.2%+19.0%21.021%
5/17/2021Ikarian Capital LLC100,000$307K0.0%N/A0.261%
5/17/2021Goldman Sachs Group Inc.30,804$95K0.0%-62.3%0.080%
5/14/2021Laurion Capital Management LP282,132$869K0.0%N/A0.736%
5/14/2021Dimensional Fund Advisors LP416,649$1.28M0.0%-4.5%1.088%
5/14/2021Algert Global LLC42,857$132K0.0%+177.1%0.112%
5/13/2021Renaissance Technologies LLC663,470$2.04M0.0%-16.8%1.732%
5/12/2021Northern Trust Corp37,878$116K0.0%+28.6%0.099%
5/12/2021Geode Capital Management LLC148,834$458K0.0%+34.5%0.388%
5/11/2021Mercer Global Advisors Inc. ADV10,500$32K0.0%N/A0.027%
5/11/2021Acadian Asset Management LLC20,936$64K0.0%-77.4%0.055%
5/10/2021GSA Capital Partners LLP95,613$294K0.0%N/A0.250%
5/10/2021Bank Julius Baer & Co. Ltd Zurich336,748$1.04M0.0%N/A0.879%
5/7/2021BlackRock Inc.77,668$239K0.0%+11.3%0.203%
5/4/2021Envestnet Asset Management Inc.10,500$32K0.0%N/A0.027%
2/18/2021Truist Financial Corp21,000$75K0.0%N/A0.075%
2/12/2021CHI Advisors LLC490,877$1.75M0.5%-15.8%1.749%
2/10/2021Renaissance Technologies LLC797,070$2.84M0.0%-8.9%2.840%
2/5/2021BlackRock Inc.69,810$248K0.0%-56.8%0.249%
1/25/2021Golden Green Inc.19,539$70K0.1%N/A0.070%
11/13/2020Morgan Stanley32,746$131K0.0%+117.7%0.117%
11/9/2020Acadian Asset Management LLC157,134$630K0.0%-13.5%0.560%
11/6/2020BlackRock Inc.161,549$647K0.0%-48.0%0.576%
10/8/2020Hikari Power Ltd19,959$80K0.0%-67.3%0.071%
9/15/2020Two Sigma Advisers LP36,880$100K0.0%+27.7%0.132%
8/14/2020BVF Inc. IL1,742,112$4.74M0.3%-19.2%6.214%
8/5/2020Russell Investments Group Ltd.39,171$106K0.0%+29.6%0.140%
5/15/2020Squarepoint Ops LLC24,436$52K0.0%N/A0.087%
5/15/2020Morgan Stanley32,920$69K0.0%-14.8%0.118%
5/15/2020Two Sigma Investments LP99,258$209K0.0%-8.6%0.355%
5/15/2020Two Sigma Advisers LP28,880$61K0.0%+74.2%0.103%
5/13/2020Connor Clark & Lunn Investment Management Ltd.85,604$181K0.0%+4.7%0.306%
5/6/2020Russell Investments Group Ltd.30,220$63K0.0%N/A0.108%
2/20/2020Geode Capital Management LLC137,555$748K0.0%+6.3%0.468%
2/14/2020Bank of America Corp DE22,811$124K0.0%-51.9%0.078%
(Data available from 1/1/2016 forward)

CRVS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRVS shares?

During the previous two years, 10 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Towerview LLC ($769K), Discovery Capital Management LLC CT ($466K), CHI Advisors LLC ($458K), Telemetry Investments L.L.C. ($427K), MYDA Advisors LLC ($229K), Acadian Asset Management LLC ($132K), and Connor Clark & Lunn Investment Management Ltd. ($103K).Learn more on CRVS's institutional investors.

What percentage of Corvus Pharmaceuticals stock is owned by institutional investors?

46.64% of Corvus Pharmaceuticals stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Which institutional investors have been buying Corvus Pharmaceuticals stock?

The following institutional investors have purchased Corvus Pharmaceuticals stock in the last 24 months: Discovery Capital Management LLC CT ($548.73K), Towerview LLC ($436.87K), MYDA Advisors LLC ($100K), Telemetry Investments L.L.C. ($61.91K), Bailard Inc. ($40.00K), Tucker Asset Management LLC ($12.87K), and Virtu Financial LLC ($6.19K).

How much institutional buying is happening at Corvus Pharmaceuticals?

Institutional investors have bought a total of 1,206,563 shares in the last 24 months. This purchase volume represents approximately $1.66M in transactions.

Which Corvus Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Corvus Pharmaceuticals stock in the last 24 months: CHI Advisors LLC ($2.18M), Acadian Asset Management LLC ($73.70K), and Connor Clark & Lunn Investment Management Ltd. ($13.49K).

How much institutional selling is happening at Corvus Pharmaceuticals?

Institutional investors have sold a total of 2,271,589 shares in the last 24 months. This volume of shares sold represents approximately $5.13M in transactions.


This page (NASDAQ:CRVS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners